Monte Rosa Therapeutics Inc. Gains 93.87%
Mon, Oct 28, 2024 at 07:35 PM
Monte Rosa Therapeutics Inc. (GLUE:NASDAQ) rocketted at $9.48, representing a gain of 93.9%. On Mon, Oct 28, 2024, GLUE:NASDAQ touched a New 2-Week High of $9.48. The stock got featured on our News Catalysts scanner on Mon, Oct 28, 2024 at 06:21 PM in the 'AGREEMENT' category. From Mon, Oct 14, 2024, the stock recorded 50.00% Up Days and 63.64% Green Days
The stock spiked on Mon, Oct 28, 2024 at $12.4 with a volume of 94M+.
About Monte Rosa Therapeutics Inc. (GLUE:NASDAQ)
Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade...
Top 10 Gainers:
- Smart for Life Inc. (SMFL:NASDAQ), 172.09%
- Hanryu Holdings, Inc. (HRYU:NASDAQ), 125.09%
- Monte Rosa Therapeutics Inc. (GLUE:NASDAQ), 93.87%
- Greenlane Holdings, Inc. (GNLN:NASDAQ), 91.92%
- Movella Holdings Inc Com (MVLA:NASDAQ), 87.5%
- Porch Group Inc. (PRCH:NASDAQ), 70.31%
- Autonomix Medical Inc. (AMIX:NASDAQ), 60.57%
- Cardio Diagnostics Holdings Inc Com (CDIO:NASDAQ), 39.82%
- Schmitt Industries, Inc. (SMIT:NASDAQ), 39.07%
- Genprex, Inc. (GNPX:NASDAQ), 38.38%